Influence of neuromelanin on oxidative pathways within the human substantia nigra

被引:76
作者
Double, KL
Ben-Shachar, D
Youdim, MBH
Zecca, L
Riederer, P
Gerlach, M
机构
[1] Prince Wales Med Res Inst, Randwick, NSW 2031, Australia
[2] Technion Israel Inst Technol, Rambam Med Ctr, Psychobiol Lab, Dept Psychiat,B Rappaport Fac Med, Haifa, Israel
[3] Technion Israel Inst Technol, Dept Pharmacol, Eve Topf Neurodegenerat Ctr, B Rappaport Fac Med, Haifa, Israel
[4] Technion Israel Inst Technol, Natl Parkinson Fdn Ctr, Haifa, Israel
[5] CNR, Inst Adv Biomed Technol, Segrate, Italy
[6] Univ Wurzburg, Dept Psychiat & Psychotherapy, D-97080 Wurzburg, Germany
[7] Univ Wurzburg, Dept Child & Youth Psychiat & Psychotherapy, D-97070 Wurzburg, Germany
基金
英国医学研究理事会;
关键词
neuromelanin; iron; substantia nigra; human; Parkinson's disease; oxidative stress;
D O I
10.1016/S0892-0362(02)00218-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neuromelanin (NM) is a dark-coloured pigment produced in the dopaminergic neurons of the human substantia nigra (SN). The function of NM within the pigmented neurons is unknown but other melanins are believed to play a protective role via attenuation of free radical damage. Experimental evidence suggests that NM may also exhibit this characteristic, possibly by directly inactivating free radical species or via its ability to chelate transition metals, such as iron. Increased tissue iron, however, may saturate iron-chelating sites on NM and a looser association between iron and NM may result in an increased, rather than decreased, production of free radical species. The death of NM-pigmented neurons in Parkinson's disease (PD) is associated with both a measurable increase in tissue iron concentrations and indices of free radical mediated damage, suggesting that NM is involved in the aetiology of this disorder. As yet, it is unknown whether NM in the parkinsonian brain differs to that found in healthy tissue and thus may fulfil a different role within this tissue. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:621 / 628
页数:8
相关论文
共 68 条
[1]   EPR investigations of the iron domain in neuromelanin [J].
Aime, S ;
Bergamasco, B ;
Biglino, D ;
Digilio, G ;
Fasano, M ;
Giamello, E ;
Lopiano, L .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1997, 1361 (01) :49-58
[2]  
Aime S, 1996, ADV NEUROL, V69, P263
[3]  
Aime S, 2000, MOVEMENT DISORD, V15, P977, DOI 10.1002/1531-8257(200009)15:5<977::AID-MDS1032>3.0.CO
[4]  
2-Q
[5]  
Aimi Y, 1996, Parkinsonism Relat Disord, V2, P69, DOI 10.1016/1353-8020(96)00004-1
[6]   Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease [J].
Banati, RB ;
Daniel, SE ;
Blunt, SB .
MOVEMENT DISORDERS, 1998, 13 (02) :221-227
[7]  
Bartzokis G, 2000, CELL MOL BIOL, V46, P821
[8]   DEGENERATION OF SUBSTANTIA-NIGRA IN CHRONIC PARKINSONS-DISEASE VISUALIZED BY TRANSCRANIAL COLOR-CODED REAL-TIME SONOGRAPHY [J].
BECKER, G ;
SEUFERT, J ;
BOGDAHN, U ;
REICHMANN, H ;
REINERS, K .
NEUROLOGY, 1995, 45 (01) :182-184
[9]  
Ben-Shachar D, 1990, J Neural Transm Suppl, V29, P251
[10]   IRON MELANIN INTERACTION AND LIPID-PEROXIDATION - IMPLICATIONS FOR PARKINSONS-DISEASE [J].
BENSHACHAR, D ;
RIEDERER, P ;
YOUDIM, MBH .
JOURNAL OF NEUROCHEMISTRY, 1991, 57 (05) :1609-1614